1Subramaniam M, Chong SA, Pek E. Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia[J]. Can J Psychiatry,2003,48(5) :345 -347.
7Gough S, Peveler R. Diabetes and its prevention: pragmatic solutions for people with schizophrenia [J]. Br J Psychiatry Suppl,2004,47:S106-111.
8Golf DC, Cather C, Evins AE, et al. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists [J]. J Clin Psychiatry, 2005,66(2) : 183 -194.
9Krosnick A, Wilson MG. A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemlc control in institutionalized patients with schizophrenia and comorbid diabetes mellitus [J ]. Clin Ther, 2005,27 ( 3 ) 320- 326.
10Raptis SA, Hatziagelaki E, Dimitriadis G, et al. Comparative effects of glimepiride and glibenclamide on blood glucose, Cpeptide and insulin concentrations in the fasting and postprandial state in normal man[J]. Exp Clin Endocrinol Diabet, 1999,107(6) : 350-355.
5American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus [J]. Diabetes Care, 1997,20:1183-1197.
6International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome[Z]. Brussels IDF,2005.
7Thonnard-Neumann E. Phenothiazines and diabetes in hospitalized women[J]. Am J Psychiatry, 1968, 124:978-982.
8Mukherjee S, Decina P, Bocola V, et al. Diabetes mellitus in schizophrenic patients [J]. Compr Psychiatry, 1996,37 : 68-73.
9Dixon L, Weiden P, Delahanty J, et al. Prevalence and correlates of diabetes in national schizophrenia samples [ J ]. Schizophr Bull, 2000, 26:903-912.
10Cohen D, Dekker JJ, Peen J, et al. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment [J]. Eur Neuropsychopharmacol, 2006, 16 : 187-194.
